Currencies / PCRX
PCRX: Pacira BioSciences Inc
26.67
USD
0.18
(0.67%)
PCRX exchange rate has changed by -0.67% for today. During the day, the instrument was traded at a low of 26.17 and at a high of 26.95.
Follow Pacira BioSciences Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PCRX News
- PharmaCorp Rx completes fourth pharmacy acquisition for $2.4 million
- Pacira (PCRX) Q2 Revenue Rises 1.7%
- Pacira earnings beat by $0.02, revenue fell short of estimates
- Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings
- Pacira (PCRX) Tops Q2 Earnings Estimates
- Pacira Q2 2025 slides: Revenue growth accelerates, margins expand amid strategic progress
- Pacira BioSciences: Worth Pondering, Strong Balance Sheet (NASDAQ:PCRX)
- Pacira BioSciences announces workforce reduction and facility changes
- PharmaCorp to acquire Western Canada pharmacy for $2.4 million
- Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
- Impax Small Cap Fund Q1 2025 Commentary (Mutual Fund:PXSAX)
- Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Grabar Law Office Investigates Claims on Behalf of Shareholders of Pacira Biosciences Inc. (PCRX)
- Pacira at RBC Conference: Strategic Growth and Gene Therapy Focus
- Pacira reports promising gene therapy data for knee osteoarthritis
- Pacira BioSciences soars 52% following InvestingPro’s October Fair Value alert
- Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Beam Therapeutics (NASDAQ:BEAM), B2Gold (AMEX:BTG)
- Pacira BioSciences Remains A 'Buy' For Pain Management With The NOPAIN Act
- Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps - Pacira BioSciences (NASDAQ:PCRX)
- Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday - Apple (NASDAQ:AAPL), Applied Optoelectronics (NASDAQ:AAOI)
- After-hours movers: Broadcom, Levi, Human and more
- Pacira BioSciences stock surges on patent litigation settlement
- Impax Small Cap Fund Q4 2024 Commentary
Daily Range
26.17
26.95
Year Range
12.62
27.64
- Previous Close
- 26.85
- Open
- 26.90
- Bid
- 26.67
- Ask
- 26.97
- Low
- 26.17
- High
- 26.95
- Volume
- 1.428 K
- Daily Change
- -0.67%
- Month Change
- 26.46%
- 6 Months Change
- 11.36%
- Year Change
- 74.31%
31 August, Sunday